Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05543694 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia

StatusRecruiting
PhasePhase 4
Started2022-10-01
View on ClinicalTrials.gov ↗

Amendment history

2026-07-10
Study Status v3
Primary completion date2024-10-01→2027-06-30
Completion date2024-10-01→2027-06-30
2023-02-06
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2022-09-16
Study Identification, Study Status v1
Study title-66 characters
ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia: A Randomized Biased Coin Sequential Allocation Trial With a Lidocaine Test Dose
2022-09-14
Original filing
To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor after receiving a lidocaine "test dose"
Trial Details
NCT Number NCT05543694
Lead Sponsor Brigham and Women's Hospital
Conditions Labor Pain, Analgesia
Enrollment 120 participants
Start Date 2022-10-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13